What explains the pathophysiology of sudden infant death syndrome (SIDS)?

Pathophysiology of Sudden Infant Death Syndrome (SIDS)

The pathology of SIDS is most consistently explained by abnormalities in brainstem serotonergic neurotransmission, particularly involving the 5-HT (serotonin) system, which disrupts critical protective responses to life-threatening stressors during sleep.

Core Neurological Abnormalities

The most robust and replicated pathological findings in SIDS involve the brainstem serotonin system, found in up to 70% of SIDS cases 1:

Serotonergic System Defects

• Decreased 5-HT1A receptor binding in the medullary raphe and adjacent regions
• Reduced 5-HT transporter binding, affecting serotonin reuptake and regulation
• Increased numbers of immature 5-HT neurons, suggesting developmental arrest
• Decreased tissue levels of serotonin and tryptophan hydroxylase (the rate-limiting enzyme for serotonin synthesis)
• No evidence of excessive serotonin degradation, ruling out metabolic causes 1

These abnormalities are critical because the brainstem serotonergic system coordinates respiratory drive, arousal from sleep, blood pressure regulation, heart rate control, thermoregulation, and upper airway patency 1. When dysfunctional, this system prevents normal protective responses to common sleep-related stressors like hypoxia, hypercapnia, or airway obstruction.

Recent high-quality evidence from a socioeconomically disadvantaged cohort confirms reduced 5-HT1A receptor binding in SIDS infants, with the defect strongly driven by preterm birth 2. Notably, premature SIDS infants showed increased 5-HT1A binding compared to premature controls, suggesting prematurity-specific alterations in serotonergic development 2.

Beyond the Brainstem: Limbic System Involvement

The pathology extends beyond isolated brainstem dysfunction 1:

• Dentate gyrus abnormalities (hippocampal component) found in 41-43% of SIDS cases
• Brainstem-limbic network dysfunction affecting autonomic regulation in response to emotional and physiological stress
• Phox2B neuron abnormalities in the retrotrapezoid nucleus, critical for CO₂ chemoreception 1

This brainstem-limbic network disruption may explain why SIDS shares pathophysiological features with sudden unexpected death in epilepsy 1.

Genetic Contributions

While SIDS is not strongly heritable, specific genetic vulnerabilities increase susceptibility 1:

Cardiac Channelopathies

• 5-10% of SIDS cases have mutations in cardiac sodium or potassium channel genes (SCN5A, connexin 43)
• These mutations cause long QT syndrome or impair gap junction function, predisposing to lethal arrhythmias
• Some mutations are directly causative; others contribute when combined with environmental stressors like acidosis 1

Serotonin Transporter Polymorphisms

• Polymorphisms enhancing serotonin transporter efficiency (L allele, 12-repeat intron 2) may be more prevalent in SIDS
• Associations vary by population (found in black infants but not Norwegian populations)
• Evidence remains inconsistent across studies 1

Metabolic Disorders

Newborn screening effectively detects medium-chain and very-long-chain acyl-CoA dehydrogenase deficiencies that could lead to sudden death, though undiagnosed inborn errors of metabolism are not more common in SIDS than controls 1.

Environmental Modulation of Pathology

Tobacco exposure significantly worsens brainstem serotonergic dysfunction 1:

• Prenatal nicotine exposure decreases medullary 5-HT1A receptor immunoreactivity
• Creates peripheral neuroplasticity with depressed hypoxic ventilatory response and prolonged apneas 3
• Increases pulmonary C-fiber density and sensitivity, triggering exaggerated apneic responses 3

Maternal stress, poverty, and prematurity appear to deflect normal serotonergic system development 2.

The Triple-Risk Model Framework

SIDS pathology operates within the triple-risk model 4, 5:

1. Vulnerable infant: Brainstem serotonergic defects, cardiac channelopathies, prematurity
2. Critical developmental period: Peak incidence 1-4 months when homeostatic control systems are immature; 90% of cases occur before 6 months 1
3. Exogenous stressor: Prone sleeping, hypoxia, hypercapnia, overheating, airway obstruction

Death occurs when the combination of these factors exceeds the infant's homeostatic threshold for survival.

Peripheral Respiratory Control Abnormalities

Recent evidence highlights peripheral chemoreceptor dysfunction 6, 3:

• Immature arterial and central CO₂ receptors
• Immature arterial oxygen receptors
• Reduced functional residual capacity (FRC) in younger infants
• Carotid body dysfunction with reduced glomus cell number and sensitivity
• Enhanced pulmonary C-fiber responses causing prolonged apneas during hypoxia

Clinical Implications

The pathology explains why:

• Supine positioning is protective: Reduces risk of airway obstruction and CO₂ rebreathing that vulnerable infants cannot respond to appropriately
• Room-sharing without bed-sharing is recommended: Allows parental monitoring while avoiding suffocation risk
• Smoking cessation is critical: Directly damages the already vulnerable serotonergic system
• Peak age is 1-4 months: Coincides with maximal immaturity of protective cardiorespiratory reflexes during a critical developmental window

The pathology is not a single defect but a constellation of brainstem, limbic, genetic, and peripheral respiratory abnormalities that converge to impair protective arousal and cardiorespiratory responses during sleep-related homeostatic challenges.